Skip to main content
SpringerLink
Log in

Uso della procalcitonina come marker del carcinoma midollare tiroideo

Using procalcitonin as a marker of medullary thyroid cancer

  • L’Osservatorio
  • Published:
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine

Summary

Here we reviewed the literature on the use of procalcitonin (PCT), a precursor of calcitonin (CT), as diagnostic marker of medullary thyroid carcinoma (MTC) in both preoperative and postsurgical setting. To date, about forty articles have been published on this topic. Some of these evaluated the reliability of PCT to detect MTC in thyroid nodule patients, and the other ones investigated the performance of PCT to identify recurrent MTC during postoperative follow-up. Based on published data, PCT measurement appears a promising and reliable serum marker for the diagnosis of MTC. The sample handling of PCT is less laborious and in specific conditions its assay could have significant impact and higher accuracy than CT. Some potential cut-offs have been reported but it would be worthwhile to establish a fixed threshold to use PCT during clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Bibliografia

  1. Wells SA Jr, Asa SL, Dralle H et al. (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610

    Article  PubMed  PubMed Central  Google Scholar 

  2. Trimboli P, Treglia G, Guidobaldi L et al. (2015) Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol (Oxf) 82:280–285

    Article  Google Scholar 

  3. Pusztaszeri MP, Bongiovanni M, Faquin WC (2014) Update on the cytologic and molecular features of medullary thyroid carcinoma. Adv Anat Pathol 21:26–35

    Article  PubMed  Google Scholar 

  4. Trimboli P, Giovanella L, Crescenzi A et al. (2014) Medullary thyroid cancer diagnosis: an appraisal. Head Neck 36:1216–1223

    Article  PubMed  Google Scholar 

  5. Trimboli P, Giovanella L (2015) Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature. Clin Chem Lab Med 53:1507–1514

    Article  CAS  PubMed  Google Scholar 

  6. Algeciras-Schimnich A, Preissner CM, Theobald JP et al. (2009) Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 94:861–868

    Article  CAS  PubMed  Google Scholar 

  7. Kratzsch J, Petzold A, Raue F et al. (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57:467–474

    Article  CAS  PubMed  Google Scholar 

  8. Kaczka K, Mikosiński S, Fendler W et al. (2010) Can procalcitonin be useful for medullary thyroid cancer? Endokrynol Pol 61:430–436

    CAS  PubMed  Google Scholar 

  9. Kaczka K, Mikosiński S, Fendler W et al. (2012) Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Adv Clin Exp Med 21:169–178

    PubMed  Google Scholar 

  10. Walter MA, Meier C, Radimerski T et al. (2010) Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 116:31–40

    CAS  PubMed  Google Scholar 

  11. Trimboli P, Lauretta R, Barnabei A et al. (2018) Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma. Int J Biol Markers 33:156–160

    Article  PubMed  Google Scholar 

  12. Machens A, Lorenz K, Dralle H (2014) Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. J Clin Endocrinol Metab 99:2986–2994

    Article  CAS  PubMed  Google Scholar 

  13. Giovanella L, Verburg FA, Imperiali M et al. (2013) Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules. Clin Chem Lab Med 51:1477–1481

    CAS  PubMed  Google Scholar 

  14. Giovanella L, Imperiali M, Piccardo A et al. (2018) Procalcitonin measurement to screen medullary thyroid carcinoma: a prospective evaluation in a series of 2705 patients with thyroid nodules. Eur J Clin Invest 48:e12934

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Giovanella L (2012) Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 120:169–170

    Article  CAS  PubMed  Google Scholar 

  16. Plebani M, Fabbri LM (2015) Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy. Clin Chem Lab Med 53:519–520

    CAS  PubMed  Google Scholar 

  17. Novotny AR, Luppa P, Rosenberg R et al. (2009) Procalcitonin can be used for monitoring sepsis in patients with medullary thyroid carcinoma. Thyroid 19:1287–1289

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicina Nucleare e Centro Tiroide, Istituto Oncologico della Svizzera Italiana, Bellinzona, Svizzera

    Luca Giovanella & Pierpaolo Trimboli

Authors
  1. Luca Giovanella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierpaolo Trimboli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Giovanella.

Ethics declarations

Conflitti di interesse

Nessuno.

Studi condotti su esseri umani e animali

Non applicabile.

Consenso informato

Non applicabile.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giovanella, L., Trimboli, P. Uso della procalcitonina come marker del carcinoma midollare tiroideo. Riv Ital Med Lab 14, 198–200 (2018). https://doi.org/10.1007/s13631-018-0200-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13631-018-0200-3

Keywords

Search

Navigation